Ovarian hyperstimulation syndrome

Critical Care Medicine

Volumn 33, Issue 10 SUPPL., 2005, Pages

  Budev, Marie M ^a   Arroliga, Alejandro C ^a   Falcone, Tommaso ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Assisted reproductive techniques; Gonadotropin stimulation; In vitro fertilisation; Ovarian hyperstimulation syndrome; Polycystic ovary syndrome

Indexed keywords

CLINICAL FEATURE; CRYOPRESERVATION; DISEASE CLASSIFICATION; FEMALE; FERTILIZATION IN VITRO; HUMAN; IATROGENIC DISEASE; INFERTILITY THERAPY; LUTEAL PHASE; OVARY DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 26444602362     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000182795.31757.CE     Document Type: Review

References (53)

1. Avecillas JF, Falcone T, Arroliga AC: Ovarian hyperstimulation syndrome. Crit Care Clin 2004; 20:679-695
2. Rydberg E, Pedersen-Bjergaard K: Effect of serum gonadotropin and chorionic gonadotropin on the human ovary. JAMA 1943; 121:1117-1122
3. Delvigne A, Rozenberg S: Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Human Reproduction Update 2003; 9:77-96
4. Delvigne A, Rozenberg S: Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review. Human Reproduction Update 2002; 8:559-577
5. Schenker JG, Weinstein D: Ovarian hyperstimulation syndrome: A current survey. Fertil Steril 1978; 30:255-268
6. Brinsden PR, Wada I, Tan SL, et al: Diagnosis, prevention, and management of ovarian hyperstimulation syndrome. Br J Obstet Gynaecol 1995; 102:767-772
7. Vasseur C, Rodien P, Beau I, et al: A chronic gonadotropin-sensitive mutation in the follicles stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N Engl J Med 2003; 349:753-759
8. Montanelli L, Delbaere A, Di Carlo C, et al A mutation in the follicle stimulation hormone receptor as a cause of familial spontaneous ovarian stimulation syndrome. J Clin Endocr Metabol 2004; 89:1255-1258
9. The Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil and Steril 2004; 82:S81-S86
10. Navot D, Bergh PA, Laufer N: The ovarian hyperstimulation syndrome in novel reproductive technologies: Prevention and treatment. Fertil Steril 1992; 58:249-261
11. Garcia-Velasco JA, Pellicer A: New concepts in the understanding of the ovarian hyperstimulation syndrome. Curr Opin Obstet Gynecol 2003; 15:251-256
12. Kol S: Lutolysis induced by a gonadotropin releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril 2004; 81:1-5
13. Levin ER, Rosen GF, Cassidenti DL, et al: Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome. J Clin Invest 1998; 102:1978-1985
14. Agrawal R, Tan SL, Wild S, et al: Serum vascular endothelial growth factor concentrations in in-vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil Steril 1999; 71:287-293
15. Abramov Y, Barac V, Nisman B, et al: Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 1997; 67:261-265
16. Chen C, Wu M, Chen H, et al: Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome. Fertil Steril 1999; 72:286-292
17. Navot D, Margalioth EJ, Luafer N, et al: Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertil Steril 1987; 48:57-61
18. Abramov Y, Elchalal U, Schenker JG. Severe OHSS. An "epidemic" of severe OHSS: A price to pay? Hum Reprod 1999; 14:2181-2185
19. MacDougall MJ, Tan SL, Balen A, et al: A controlled study comparing patients with and without polycystic ovaries undergoing in vitro fertilization. Hum Reprod 1993; 8:233-237
20. Smitz J, Camus M, Devroey P, et al: Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in vitro fertilization. Hum Reprod 1990; 5:933-937
21. Delvigne A, Demoulin A, Smitz J, et al: The ovarian hyperstimulation syndrome in vitro fertilization: A Belgian multicentric study. I. Clinical and biological features. Hum Reprod 1993; 8:1353-1356
22. Navot D, Relou A, Birkenfeld A, et al: Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am J Obstet Gynecol 1998; 159:210-215
23. Enskog A, Heriksson M, Unander M, et al: Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril 1999; 71:808-814
24. Kistner RW: Induction of ovulation with clomiphene citrate (clomid). Obstet Gynecol Sun 1965; 20:873-900
25. van Wely M, Westergaard LG, Bossuyt PM, et al: Effectiveness of human menopausal gonadotropin versus recombinant follicle stimulation hormone for controlled ovarian hyperstimulation in assisted reproductive cycles. A meta-analysis. Fertil Steril 2003; 80:1086-1093
26. Felberbaum RE, Diedrich K: Gonadotrophin releasing hormone antagonists: Will they replace the agonists? Reprod Biomed Online 2003; 6:43-53
27. Aboulghar M, Evers JH, Al-Inany H: Intravenous albumin for the preventing severe ovarian hyperstimulation syndrome: A Cochran review. Hum Reprod 2002; 17:3027-3032
28. Friedman CI, Schmidt GE, Chang FE, et al: Severe ovarian hyperstimulation syndrome following follicular aspiration. Am J Obstet Gynecol 1984; 150:436-437
29. Rabau E, David A, Serr DM, et al: Human menopausal gonadotropins for anovulation and sterility. Am J Obstet Gynecol 1967; 98:92-98
30. Schenker JG, Weinstein D: Ovarian hyperstimulation syndrome: A current survey. Fertil Steril 1978; 30:255-268
31. Mathur RS, Akande AV, Keay SD, et al: Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 2000; 73:901-907
32. Semba S, Moriya T, Youssef EM, et al: An autopsy case of ovarian hyperstimulation syndrome of massive pulmonary edema and pleural effusions. Pathol Int 2000; 50:549-552
33. Shanbhag S, Bhattacharya S: Current management of ovarian hyperstimulation syndrome. Hosp Med 2002; 63:528-532
34. Fabreques F, Balasch J, Manau D, et al: Haematocrit, leukocyte and platelet counts and the severity of the ovarian hyperstimulation syndrome. Hum Reprod 1998; 13:2406-2410
35. Pham J, Maneglia R, Makhlouk B, et al: Syndrome of ovarian hyperstimulation. Report of severe iatrogenic complication. Prese Med 1995; 24:1603-1604
36. Balasch J, Fabreques F, Arroyo V, et al: Treatment of severe ovarian hyperstimulation syndrome by a conservative medical approach. Acta Obstet Gynecol Scand 1996; 75:662-667
37. Fabreques F, Balasch J, Gines P, et al: Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome. Am J Gastroenterol 1999; 94:994-999
38. Takamizawa S, Shibahara H, Taneichi A, et al: Dynamic changes of the immunoglobulins in patients with ovarian hyperstimulation syndrome: Efficacy of a novel treatment using peritoneo-venous shunt. Am J Reprod Immunol 2002; 47:25-30
39. Abramov Y, Elchalal U, Schenker JG, et al: Febrile morbidity in severe and critical ovarian hyperstimulation syndrome: A multicenter study. Hum Reprod 1993; 13:3128-3131
40. Serour GI, Aboulghar M, Mansour R, et al: Complications of medically assisted conception in 3,500 cycles. Fertil Steril 1998; 70:638-642
41. Stewart JA, Hamilton PJ, Murdoch AP: Thromboembolic disease associated with ovarian hyperstimulation and assisted conception techniques. Hum Reprod 1997; 12:2167-2173
42. Turkistani IM, Ghourab SA, Al-Sheikh OH, et al: Central retinal artery occlusion associated with severe ovarian hyperstimulation syndrome. Eur J Ophthalmol 2001; 11:313-315
43. Fawzy M, Harrison RF, Walshe J: Ovarian hyperstimulation syndrome: Diagnosis, prevention, and management. Ir Med J 1998; 91:86-87
44. Zosmer A, Katz Z, Lancet M, et al: Adult respiratory distress syndrome complicating ovarian hyperstimulation syndrome. Fertil Steril 1987; 47:524-526
45. Borenstein R, Elhalah U, Lunenfeld B, et al: Severe ovarian hyperstimulation syndrome: A reevaluated approach. Fertil Steril 1989; 51:791-795
46. Brower RG, Matthay MA, Morris A, et al: The acute respiratory distress syndrome network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342:1301-1308
47. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342:1334-1349
48. Shigematsu T, Kubota E, Arman M: Adult respiratory distress syndrome as a manifestation of ovarian hyperstimulation syndrome. Int J Gynaecol Obstet 2000; 69:169-170
49. Abuzeid MI, Nassar Z, Massaad Z, et al: Pig-tail catheter for the treatment of ascites associated with ovarian hyperstimulation syndrome. Hum Reprod 2003; 18:370-373
50. Fukaya T, Chida S, Terada Y, et al: Treatment of severe ovarian hyperstimulation syndrome by ultra filtration and re-infusion of ascitic fluid. Fertil Steril 1994; 77:1302-1303
51. Pride SM, Yuen BH, Moon YS: Clinical, endocrinologic, and intraovarian prostacyclin F responses to H-1 receptor blockade in the ovarian hyperstimulation syndrome: Studies in the rabbit model. Am J Obstet Gynecol 1986; 154:1155-1160
52. Gergely RZ, Paldi E, Erlik Y, et al: Treatment of ovarian hyperstimulation syndrome by antihistamine. Obstet Gynecol 1976; 47:83-85
53. Chew S, Ng SC: Laparoscopic treatment of a twisted hyperstimulated ovary after IVF. Singapore Med J 2001; 42:228-229